Showing results (51-60 of 255) with videos related to
Sort By:
Pageof 26
Bulletin Du Cancer|November 17, 1998
[Urothelial tumors of the bladder]F André, J C Soria, P Beuzeboc, et al.Bulletin Du Cancer|February 13, 2009
[Advances in the treatment of thyroid cancer in the era of molecularly targeted therapies]G Malouf, E Baudin, J-C Soria, et al.Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|May 25, 2010
[The journey of a molecule, from trials to approval: the specific area of oncology]T Lebret, F Giuliano, J-C Soria, et al.Canadian Journal of Microbiology|June 2, 1998
Simplified reverse transcription polymerase chain reaction procedure with detection by microplate hybridization for routine screening of hepatitis A virusC Arnal, V Ferré-Aubineau, B Besse, et al.Bulletin Du Cancer|December 26, 2009
[KRAS status versus EGFR status in lung cancer therapy]L Lacroix, B Besse, J-M Bidart, et al.Annales De Biologie Clinique|January 1, 1988
[Comparison of 2 immunoenzyme methods for the determination of anti-cytomegalovirus IgM]S Billaudel, B Besse, A Mézière, et al.Bulletin Du Cancer|August 1, 1997
[Second primary cancers after small-cell lung cancer]J C Soria, J M Bréchot, B Lebeau, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 21, 2017
Targeting chromatin defects in selected solid tumors based on oncogene addiction, synthetic lethality and epigenetic antagonismD Morel, G Almouzni, J-C Soria, et al.Bulletin Du Cancer|December 19, 2008
[Everolimus (RAD001) and solid tumours: a 2008 summary]A Lévy, L Albiges Sauvin, C Massard, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 13, 2018
Epigenetic modifiers as new immunomodulatory therapies in solid tumoursS Aspeslagh, D Morel, J-C Soria, et al.Pageof 26